Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma

Antoni Ribas*, Richard Kefford, Margaret A. Marshall, Cornelis J A Punt, John B. Haanen, Maribel Marmol, Claus Garbe, Helen Gogas, Jacob Schachter, Gerald Linette, Paul Lorigan, Kari L. Kendra, Michele Maio, Uwe Trefzer, Michael Smylie, Grant A. McArthur, Brigitte Dreno, Paul D. Nathan, Jacek MacKiewicz, John M. KirkwoodJesus Gomez-Navarro, Bo Huang, Dmitri Pavlov, Axel Hauschild

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

544 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences